Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 10/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
| ▸ | CDC25A | P30304 | 6/20 | 0.36 |
| ▸ | CDC25B | P30305 | 6/20 | 0.36 |
| ▸ | CDC25C | P30307 | 5/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | MPEG1 | Q2M385 | 5/20 | 0.33 |
| ▸ | XIAP | P98170 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9004869 | 0.86 | NAAA (0.40) | ALDH1A1TDP1LMNAPOLBRECQL | |
| SCHEMBL2137246 | 0.80 | ALDH1A1 (0.45) | ALDH1A1TDP1ALOX5MAPTTHRB | |
| SCHEMBL9004894 | 0.78 | ALDH1A1 (0.39) | ALDH1A1TDP1LMNAPOLBRECQL | |
| SCHEMBL27488484 | 0.77 | ALDH1A1 (0.36) | ALDH1A1TDP1LMNAPOLBRECQL | |
| SCHEMBL28484221 | 0.75 | ALDH1A1 (0.42) | ALDH1A1TDP1LMNAPOLBRECQL | |
| SCHEMBL2142689 | 0.74 | CYP1A2 (0.36) | ALDH1A1TDP1ALOX5PPARGPPARA | |
| Acetic Acid SCHEMBL9004863 | 0.73 | ALDH1A1 (0.44) | ALDH1A1TDP1LMNAPOLBRECQL | |
| SCHEMBL18982985 | 0.72 | SCD (0.41) | ALDH1A1ALOX5PPARGPPARATHRB | |
| SCHEMBL18982982 | 0.72 | SCD (0.41) | ALDH1A1ALOX5PPARGPPARATHRB | |
| SCHEMBL8069818 | 0.72 | ALOX5 (0.42) | ALDH1A1TDP1LMNAPOLBRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117586119-A | Synthesis method of 3-oxo-2-amyl-cyclopentenyl methyl acetate | 浙江新化化工股份有限公司 | 2024-02-23 | — | — | CN | claimed |
| EP-0583564-B1 | Process for the preparation of 3-oxo-2-pentyl-1-cyclopentene alkyl acetates | FIRMENICH & CIE (CH) | 1996-10-09 | — | — | EP | claimed |
| EP-0583564-A1 | Process for the preparation of 3-oxo-2-pentyl-1-cyclopentene alkyl acetates | FIRMENICH SA (CH) | 1994-02-23 | — | — | EP | claimed |
| CN-109134251-A | A kind of preparation method of 3- oxo -2- amyl-cyclopentenyl methyl acetate | 泛亚（武汉）食品科技有限公司 | 2019-01-04 | — | — | CN | disclosed |
| US-20090036692-A1 | Process for Production of Substituted Cyclopentanone | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2009-02-05 | — | — | US | disclosed |
| EP-2000455-A2 | Process for production of substituted cyclopentanone | Asahi Kasei Chemicals Corporation (JP) | 2008-12-10 | — | — | EP | disclosed |
| EP-1900720-A1 | PROCESS FOR PRODUCTION OF SUBSTITUTED CYCLOPENTANONE | Asahi Kasei Chemicals Corporation (JP) | 2008-03-19 | — | — | EP | disclosed |
| EP-0583564-B1 | Process for the preparation of 3-oxo-2-pentyl-1-cyclopentene alkyl acetates | FIRMENICH & CIE (CH) | 1996-10-09 | — | — | EP | disclosed |
| EP-0583564-B1 | Process for the preparation of 3-oxo-2-pentyl-1-cyclopentene alkyl acetates | FIRMENICH & CIE (CH) | 1996-10-09 | — | — | EP | disclosed |
| EP-0583564-A1 | Process for the preparation of 3-oxo-2-pentyl-1-cyclopentene alkyl acetates | FIRMENICH SA (CH) | 1994-02-23 | — | — | EP | disclosed |
| EP-0583564-A1 | Process for the preparation of 3-oxo-2-pentyl-1-cyclopentene alkyl acetates | FIRMENICH SA (CH) | 1994-02-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036692-A1 | Process for Production of Substituted Cyclopentanone | COASY, POR, DHPS | ALDH1A1 899/4885TDP1 4390/4885LMNA 4616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.